Helicobacter pylori -induced chronic gastritis and assessing risks for gastric cancer

Gastroenterology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Carrasco, Gonzalo ^a   Corvalan, Alejandro H ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P73; UVOMORULIN;

ARTICLE; CANCER RISK; CANCER STAGING; CELL CYCLE ARREST; CHRONIC GASTRITIS; CLINICAL ASSESSMENT TOOL; DNA METHYLATION; ENVIRONMENTAL FACTOR; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HELICOBACTER INFECTION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HYGIENE; LAMINA PROPRIA; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; OPERATIVE LINK FOR GASTRITIS ASSESSMENT; PROMOTER REGION; RISK ASSESSMENT; STOMACH CANCER; STOMACH MUCOSA; TUMOR SUPPRESSOR GENE;

EID: 84883167708     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2013/393015     Document Type: Article

References (53)

1. Figura N., Oderda G., Reflections on the first description of the presence of helicobacter species in the stomach of mammals. Helicobacter 1996 1 1 4 5 2-s2.0-0030088914
2. Kidd M., Modlin I. M., A century of Helicobacter pylori. Paradigms lost-paradigms regained. Digestion 1998 59 1 1 15 2-s2.0-0031973044 10.1159/000007461
3. Schindler R., Gastritis 1947 London, UK William Heinmann
4. Marshall B. J., Warren J. R., Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. The Lancet 1984 1 8390 1311 1315 2-s2.0-0021259505
5. Jacobson B. C., Crawford J. M., Farraye F. A., Odze R. D., Goldblum J. R., GI tract endoscopic and tissue processing techniques and normal histology in surgical pathology of the GI tract. Liver, Biliary Tract and Pancreas 2009 Elsevier
6. Malaty H. M., Epidemiology of Helicobacter pylori infection. Best Practice and Research 2007 21 2 205 214 2-s2.0-33947229036 10.1016/j.bpg.2006. 10.005
7. Shimizu T., Akamatsu T., Ota H., Katsuyama T., Immunohistochemical detection of Helicobacter pylori in the surface mucous gel layer and its clinicopathological significance. Helicobacter 1996 1 4 197 206 2-s2.0-0030309654
8. Carneiro F., Fonseca E., Sobrinho-Simoes M., Epithelial degeneration induced by Helicobacter pylori. Human Pathology 1992 23 11 1314 1315 2-s2.0-0026481296 10.1016/0046-8177(92)90305-M
9. Leung K. M., Hui P. K., Chan W. Y., Thomas T. M. M., Helicobacter pylori -related gastritis and gastric ulcer: a continuum of progressive epithelial degeneration. American Journal of Clinical Pathology 1992 98 6 569 574 2-s2.0-0026438820
10. Genta R. M., Lew G. M., Graham D. Y., Changes in the gastric mucosa following eradication of Helicobacter pylori. Modern Pathology 1993 6 3 281 289 2-s2.0-0027603209
11. Dixon M. F., Genta R. M., Yardley J. H., Correa P., Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. The American Journal of Surgical Pathology 1996 20 10 1161 1181
12. Correa P., Chronic gastritis: a clinico-pathological classification. American Journal of Gastroenterology 1988 83 5 504 509 2-s2.0-0023880608
13. Correa P., Cuello C., Duque E., Gastric cancer in Colombia. III. Natural history of precursor lesions. Journal of the National Cancer Institute 1976 57 5 1027 1035 2-s2.0-0017086391
14. Cuello C., Correa P., Haenszel W., Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. Journal of the National Cancer Institute 1976 57 5 1015 1020 2-s2.0-0017088732
15. Haenszel W., Correa P., Cuello C., Gastric cancer in Colombia. II. Case control epidemiologic study of precursor lesions. Journal of the National Cancer Institute 1976 57 5 1021 1026 2-s2.0-0017137741
16. Correa P., Haenszel W., Cuello C., Zavala D., Fontham E., Zarama G., Tannenbaum S., Collazos T., Ruiz B., Gastric precancerous process in a high risk population: cohort follow-up. Cancer Research 1990 50 15 4737 4740 2-s2.0-0025315115
17. Ohata H., Kitauchi S., Yoshimura N., Mugitani K., Iwane M., Nakamura H., Yoshikawa A., Yanaoka K., Arii K., Tamai H., Shimizu Y., Takeshita T., Mohara O., Ichinose M., Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. International Journal of Cancer 2004 109 1 138 143 2-s2.0-10744222728 10.1002/ijc.11680
18. Conteduca V., Sansonno D., Lauletta G., Russi S., Ingravallo G., Dammacco F., H. pylori infection and gastric cancer: state of the art (Review). International Journal of Oncology 2013 42 1 5 18
19. Gonzalez C. A., Agudo A., Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. International Journal of Cancer 2012 130 4 745 753
20. Correa P., Piazuelo M. B., The gastric precancerous cascade. Journal of Digestive Diseases 2012 13 1 2 9
21. Delahay R. M., Rugge M., Pathogenesis of Helicobacter pylori infection. Helicobacter 2012 17 supplement 1 9 15
22. González C. A., Figueiredo C., Lic C. B., Ferreira R. M., Pardo M. L., Ruiz Liso J. M., Alonso P., Sala N., Capella G., Sanz-Anquela J. M., Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. American Journal of Gastroenterology 2011 106 5 867 874 2-s2.0-79955601017 10.1038/ajg.2011.1
23. Saraga E. P., Gardiol D., Costa J., Gastric dysplasia. A histological follow-up study. American Journal of Surgical Pathology 1987 11 10 788 796 2-s2.0-0023640070
24. Coma del Corral M. J., Pardo-Mindan F. J., Razquin S., Ojeda C., Risk of cancer in patients with gastric dysplasia: follow-up study of 67 patients. Cancer 1990 65 9 2078 2085 2-s2.0-0025250269
25. Koch H. K., Oehlert M., Oehlert W., An evaluation of gastric dysplasia in the years 1986 and 1987. Pathology Research and Practice 1990 186 1 80 84 2-s2.0-0025237763
26. Whiting J. L., Sigurdsson A., Rowlands D. C., Hallissey M. T., Fielding J. W. L., The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002 50 3 378 381 2-s2.0-0036181067 10.1136/gut.50.3.378
27. Rugge M., Cassaro M., Di Mario F., Leo G., Leandro G., Russo V. M., Pennelli G., Farinati F., The long term outcome of gastric non-invasive neoplasia. Gut 2003 52 8 1111 1116 2-s2.0-0037622917 10.1136/gut.52.8.1111
28. Ramesar K. C. R. B., Sanders D. S. A., Hopwood D., Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma. Journal of Clinical Pathology 1987 40 11 1287 1290 2-s2.0-0023607856
29. Silva S., Filipe M. I., Pinho A., Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study. Gut 1990 31 10 1097 1104 2-s2.0-0025009380
30. Rokkas T., Filipe M. I., Sladen G. E., Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991 32 10 1110 1113 2-s2.0-0025943386
31. Conchillo J. M., Houben G., de Brune A., Stockbrügger R., Is type III intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma? European Journal of Cancer Prevention 2001 10 4 307 312 2-s2.0-0034908047 10.1097/00008469-200108000-00003
32. Vannella L., Lahner E., Annibale B., Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World Journal of Gastroenterology 2012 18 12 1279 1285
33. Rugge M., Meggio A., Pennelli G., Piscioli F., Giacomelli L., De Pretis G., Graham D. Y., Gastritis staging in clinical practice: the OLGA staging system. Gut 2007 56 5 631 636 2-s2.0-34247509658 10.1136/gut.2006.106666
34. Capelle L. G., de Vries A. C., Haringsma J., The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointestinal Endoscopy 2010 71 7 1150 1158
35. Rugge M., de Boni M., Pennelli G., De Bona M., Giacomelli L., Fassan M., Basso D., Plebani M., Graham D. Y., Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Alimentary Pharmacology and Therapeutics 2010 31 10 1104 1111 2-s2.0-77951239904 10.1111/j.1365-2036.2010.04277.x
36. Rugge M., Kim J. G., Mahachai V., Miehlke S., Pennelli G., Russo V. M., Perng C. L., Chang F. Y., Tandon R. K., Singal D. K., Sung J. J. Y., Valenzuela J. E., Realdi G., Dore M. P., Graham D. Y., OLGA gastritis staging in young adults and country-specific gastric cancer risk. International Journal of Surgical Pathology 2008 16 2 150 154 2-s2.0-42249108659 10.1177/1066896907307238
37. Stemmermann G. N., Intestinal metaplasia of the stomach. A status report. Cancer 1994 74 2 556 564
38. Rugge M., Fassan M., Pizzi M., Pennelli G., Nitti D., Farinati F., Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. Human Pathology 2011 42 10 1539 1544
39. Rugge M., Correa P., Dixon M. F., Fiocca R., Hattori T., Lechago J., Leandro G., Price A. B., Sipponen P., Solcia E., Watanabe H., Genta R. M., Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Alimentary Pharmacology and Therapeutics 2002 16 7 1249 1259 2-s2.0-0036024197 10.1046/j.1365-2036.2002.01301.x
40. Yasui W., Sentani K., Sakamoto N., Anami K., Naito Y., Oue N., Molecular pathology of gastric cancer: research and practice. Pathology, Research and Practice 2011 207 10 608 612
41. Gigek C. O., Chen E. S., Calcagno D. Q., Wisnieski F., Burbano R. R., Smith M. A., Epigenetic mechanisms in gastric cancer. Epigenomics 2012 4 3 279 294
42. Corvalan A. H., Maturana M. J., Recent patents of DNA methylation biomarkers in gastrointestinal oncology. Recent Patents on DNA and Gene Sequences 2010 4 3 202 209 2-s2.0-79952746328 10.2174/187221510794751695
43. Zhao C., Bu X., Promoter methylation of tumor-related genes in gastric carcinogenesis. Histology and Histopathology 2012 27 10 1271 1282
44. Chan A. O. O., Lam S. K., Wong B. C. Y., Wong W. M., Yuen M. F., Yeung Y. H., Hui W. M., Rashid A., Kwong Y. L., Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003 52 4 502 506 2-s2.0-0037537477 10.1136/gut.52.4.502
45. Chan A. O. O., Rashid A., CpG island methylation in precursors of gastrointestinal malignancies. Current Molecular Medicine 2006 6 4 401 408 2-s2.0-33744813317 10.2174/156652406777435417
46. Maekita T., Nakazawa K., Mihara M., Nakajima T., Yanaoka K., Iguchi M., Arii K., Kaneda A., Tsukamoto T., Tatematsu M., Tamura G., Saito D., Sugimura T., Ichinose M., Ushijima T., High levels of aberrant DNA methylation in Helicobacter pylori -infected gastric mucosae and its possible association with gastric cancer risk. Clinical Cancer Research 2006 12 3, part 1 989 995 2-s2.0-32944459562 10.1158/1078-0432.CCR-05-2096
47. Ohki R., Nemoto J., Murasawa H., Oda E., Inazawa J., Tanaka N., Taniguchi T., Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. The Journal of Biological Chemistry 2000 275 30 22627 22630 2-s2.0-0034725694 10.1074/jbc.C000235200
48. Schneider B. G., Peng D. F., Camargo M. C., Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. International Journal of Cancer 2010 127 11 2588 2597
49. Bernal C., Aguayo F., Villarroel C., Vargas M., Díaz I., Ossandon F. J., Santibáñez E., Palma M., Aravena E., Barrientos C., Corvalan A. H., Reprimo as a potential biomarker for early detection in gastric cancer. Clinical Cancer Research 2008 14 19 6264 6269 2-s2.0-58149147357 10.1158/1078-0432.CCR-07-4522
50. Sapari N. S., Loh M., Vaithilingam A., Soong R., Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One 2012 7 4 e36275
51. Carrasco G., Diaz J., Valbuena J. R., Ibanez P., Rodriguez P., Araya G., Rodriguez C., Torres J., Duarte I., Aravena E., Mena F., Barrientos C., Corvalan A. H., Overexpression of p73 as a tissue marker for high-risk gastritis. Clinical Cancer Research 2010 16 12 3253 3259 2-s2.0-77953721353 10.1158/1078-0432.CCR-09-2491
52. Faratian D., Systems pathology. Breast Cancer Research 2010 12 supplement 4, article S4 2-s2.0-78650882233 10.1186/bcr2733
53. A. I. Saeed, N. K. Bhagabati, J. C. Braisted et al., TM4microarray software suite, Methods in Enzymology, vol. 411,pp. 134-193, 2006.